Oculis Holding
OCS
Oculis Holding (OCS) news
Recent news
Oculis signs asset purchase agreement with Accure Therapeutics for lead candidate, PrivosegTor, fortifying Oculis’ position as an emerging leading neuro-ophthalmology company
AInvest Wire · Aug 10, 2026Oculis Holding Oculis signs asset buy pact with Accure Therapeutics for lead candidate, PrivosegTor, fortifying Oculis'
AInvest Wire · Aug 10, 2026Oculis Holding AG - FDA confirms existing PrivoSegtor data can be used for IND application in acute MS relapses planned for submission in Q4
AInvest Wire · Aug 3, 2026OCS to offer 218.5p per Mittie share
AInvest Wire · Jul 21, 2026Oculis Holding AG <OCS.O>: Needham cuts target price to $38 from $46
Oculis Holding AG : Needham cuts target price to $38 from $46
AInvest Wire · Jun 1, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.